Exclusive Partnership for North America, Europe and Asia - Launching
P-Gels -- Soft Gel Offering
RESEARCH TRIANGLE PARK, N.C. and BARRANQUILLA, Columbia, Jan. 19, 2012
/CNW/ - Patheon and PROCAPS S.A. are pleased to announce an agreement
to provide the pharmaceutical industry a new world-class line of
prescription pharmaceutical soft-gel product development and
manufacturing services. The offering will be branded as "P-Gels" soft
gels and the partnership will give Patheon rights to market PROCAPS'
soft gel technology and manufacturing capabilities in North America,
Europe and Asia.
"This exclusive agreement is part of our recently announced strategy to
strengthen our core operations and product offerings," said Jim Mullen,
Patheon's Chief Executive Officer. "By combining PROCAPS'
manufacturing capabilities and proprietary technology with our global
experience, reach and customer service, we are positioned to provide
our customers royalty-free soft gel capsule solutions for their
"PROCAPS is pleased to enter into this agreement with Patheon, one of
the leading providers of contract development and manufacturing
services in the world," said Ruben Minski, PROCAPS Chief Executive
Officer. "This partnership truly provides us with a great opportunity
to leverage our quality soft gel capabilities across the Globe through
Patheon's customers and beyond."
"The addition of commercial scale soft gel capacity to our full offering
of dosage forms, which includes parenteral, solid and liquid
technologies, creates a more comprehensive array of options for our
clients," commented Michael Lytton, Executive Vice President, Corporate
Development and Strategy & General Counsel. "Soft gel oral drug
delivery offers many advantages to some of the more challenging
compounds being developed by the pharmaceutical industry today and the
collaboration with PROCAPS builds on Patheon's successful SoluPathTM solution set for compounds with solubility challenges. We look forward
to partnering with our current and future customers to provide them
with P-Gels soft gel capability."
The capabilities Patheon gains via the P-Gels offering include large
scale commercial supply of prescription soft gel capsules for the North
American, European and Asian markets. PROCAPS is an established,
multinational company with over 3,000 employees and rich history of
providing quality products in food supplements, as well as OTC and Rx
pharmaceuticals. PROCAPS has been developing and manufacturing soft
gel capsules since 1977 and currently has capacity to manufacture up to
nine billion capsules per year.
The soft gel dosage form provides important advantages for drug delivery
and consumer experience. It offers rapid and consistent absorption of
drugs and consistent delivery of highly potent drugs that require small
dosages. In many cases, soft gels can be used to improve the
solubility of drugs that pose bioavailability challenges. Consumer
advantages include reliable delivery, taste masking, ease of
swallowing, and rapid onset. Patient feedback surveys consistently
rate soft gels as the preferred dosage form.
Patheon Inc. (TSX: PTI) is a leading global provider of contract
development and manufacturing services to the global pharmaceutical
industry. The company provides the highest quality products and
services to approximately 300 of the world's leading pharmaceutical and
biotechnology companies. Its services range from preclinical
development through commercial manufacturing of a full array of dosage
forms including parenteral, soft gel, solid and liquid forms.
The company's comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and commercialization.
The company's integrated development and manufacturing network of 10
manufacturing facilities, nine development centers and one clinical
trial material packaging facility across North America and Europe,
enables customer products to be launched with confidence anywhere in
the world. www.patheon.com
About PROCAPS S.A.
PROCAPS S.A. is a dynamic and innovative company established to be a
specialized developer and manufacturer of soft gel capsules to supply
the pharmaceutical (OTC & Rx), cosmetic and nutritional supplement
industries. PROCAPS is Colombian-based with GMP, ISO9000 and 14000
certified manufacturing facilities throughout Latin American serving
customers in more than 50 countries. www.softigel.com
SOURCE Patheon Inc.
For further information:
Investor Relations and Corporate Communications
Tel: (919) 226-3313
Tel: +(57) 5 3719-801